Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies
出版年份 2023 全文链接
标题
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies
作者
关键词
-
出版物
Nature Communications
Volume 14, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-02-14
DOI
10.1038/s41467-023-36561-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters
- (2023) Ai-ris Y. Collier et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody Response to Omicron BA.4–BA.5 Bivalent Booster
- (2023) Qian Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1
- (2023) Jessica Miller et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses
- (2022) Alexandra C. Walls et al. CELL
- Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose
- (2022) Constanze Kuhlmann et al. LANCET
- COVID-19 will continue but the end of the pandemic is near
- (2022) Christopher J L Murray LANCET
- Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity
- (2022) Bo Meng et al. NATURE
- Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
- (2022) Delphine Planas et al. NATURE
- Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
- (2022) Juan Manuel Carreño et al. NATURE
- Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
- (2022) Sandile Cele et al. NATURE
- Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
- (2022) Raquel Viana et al. NATURE
- Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
- (2022) Rigel Suzuki et al. NATURE
- Antibody-mediated neutralization of SARS-CoV-2
- (2022) Henning Gruell et al. IMMUNITY
- Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2
- (2022) Olha Puhach et al. NATURE MEDICINE
- Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies
- (2022) Timothée Bruel et al. NATURE MEDICINE
- Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
- (2022) Nick Andrews et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19
- (2022) Myron J. Levin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar
- (2022) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa
- (2022) Juliet R. C. Pulliam et al. SCIENCE
- SARS-CoV-2 transmission, persistence of immunity, and estimates of Omicron’s impact in South African population cohorts
- (2022) Kaiyuan Sun et al. Science Translational Medicine
- LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
- (2022) Kathryn Westendorf et al. Cell Reports
- Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
- (2022) Aekkachai Tuekprakhon et al. CELL
- Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2
- (2022) Guillaume Martin-Blondel et al. JOURNAL OF INFECTION
- A monoclonal antibody stands out against omicron subvariants: a call to action for a wider access to bebtelovimab
- (2022) Maxime Hentzien et al. LANCET INFECTIOUS DISEASES
- BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
- (2022) Yunlong Cao et al. NATURE
- Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa
- (2022) Houriiyah Tegally et al. NATURE MEDICINE
- Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance
- (2022) Lirong Cao et al. NATURE MEDICINE
- Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5
- (2022) Nicole P. Hachmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune boosting by B.1.1.529 ( Omicron) depends on previous SARS-CoV-2 exposure
- (2022) Catherine J. Reynolds et al. SCIENCE
- SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies
- (2022) Kevin W. Ng et al. Science Translational Medicine
- Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5
- (2022) Izumi Kimura et al. CELL
- Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses
- (2022) Clarisa M. Buckner et al. CELL
- Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant
- (2022) Akatsuki Saito et al. Cell Host & Microbe
- Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75
- (2022) Yunlong Cao et al. Cell Host & Microbe
- WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed
- (2022) Mary Y Wu et al. LANCET
- Resistance of SARS-CoV-2 omicron subvariant BA.4.6 to antibody neutralisation
- (2022) Qian Wang et al. LANCET INFECTIOUS DISEASES
- Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies
- (2022) Daniel J Sheward et al. LANCET INFECTIOUS DISEASES
- Lung cell entry, cell–cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75
- (2022) Prerna Arora et al. LANCET INFECTIOUS DISEASES
- Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial
- (2022) Spyros Chalkias et al. NATURE MEDICINE
- Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice
- (2022) Suzanne M. Scheaffer et al. NATURE MEDICINE
- Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6
- (2022) Nicole P. Hachmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
- (2022) Young-Jun Park et al. SCIENCE
- Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants
- (2022) Qian Wang et al. CELL
- Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2
- (2022) Panke Qu et al. Cell Host & Microbe
- Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
- (2022) Yunlong Cao et al. NATURE
- Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster
- (2022) Chaitanya Kurhade et al. NATURE MEDICINE
- Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster
- (2022) Meredith E. Davis-Gardner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies
- (2022) Timothée Bruel et al. Cell Reports Medicine
- N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
- (2021) Matthew McCallum et al. CELL
- Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
- (2021) Delphine Planas et al. NATURE MEDICINE
- Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19
- (2021) Meagan P. O’Brien et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hybrid immunity
- (2021) Shane Crotty SCIENCE
- Immune imprinting and SARS-CoV-2 vaccine design
- (2021) Adam K. Wheatley et al. TRENDS IN IMMUNOLOGY
- Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab
- (2021) Anil Gupta et al. NEW ENGLAND JOURNAL OF MEDICINE
- Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study
- (2021) Blandine Monel et al. EBioMedicine
- SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology
- (2020) Natacha S. Ogando et al. JOURNAL OF GENERAL VIROLOGY
- Syncytia formation by SARS‐CoV‐2 infected cells
- (2020) Julian Buchrieser et al. EMBO JOURNAL
- Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
- (2020) Wen Shi Lee et al. Nature Microbiology
- IgA dominates the early neutralizing antibody response to SARS-CoV-2
- (2020) Delphine Sterlin et al. Science Translational Medicine
- The Genome Landscape of the African Green Monkey Kidney-Derived Vero Cell Line
- (2014) Naoki Osada et al. DNA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now